Cargando…
Multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settings
BACKGROUND: Multinational clinical trials are logistically complex and require close coordination between various stakeholders. They must comply with global clinical standards and are accountable to multiple regulatory and ethical bodies. In resource-limited settings, it is challenging to understand...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863846/ https://www.ncbi.nlm.nih.gov/pubmed/29566732 http://dx.doi.org/10.1186/s13063-018-2563-1 |
_version_ | 1783308445646061568 |
---|---|
author | Mtove, George Kimani, Joshua Kisinza, William Makenga, Geofrey Mangesho, Peter Duparc, Stephan Nakalembe, Miriam Phiri, Kamija S. Orrico, Russell Rojo, Ricardo Vandenbroucke, Pol |
author_facet | Mtove, George Kimani, Joshua Kisinza, William Makenga, Geofrey Mangesho, Peter Duparc, Stephan Nakalembe, Miriam Phiri, Kamija S. Orrico, Russell Rojo, Ricardo Vandenbroucke, Pol |
author_sort | Mtove, George |
collection | PubMed |
description | BACKGROUND: Multinational clinical trials are logistically complex and require close coordination between various stakeholders. They must comply with global clinical standards and are accountable to multiple regulatory and ethical bodies. In resource-limited settings, it is challenging to understand how to apply global clinical standards to international, national, and local factors in clinical trials, making multiple-level stakeholder engagement an important element in the successful conduct of these clinical trials. MAIN BODY: During the planning and implementation of a large multinational clinical trial for intermittent preventive treatment of malaria in pregnancy in resource-limited areas of sub-Saharan Africa, we encountered numerous challenges, which required implementation of a range of engagement measures to ensure compliance with global clinical and regulatory standards. These challenges included coordination with ongoing global malaria efforts, heterogeneity in national regulatory structures, sub-optimal healthcare infrastructure, local practices and beliefs, and perspectives that view healthcare providers with undue trust or suspicion. In addition to engagement with international bodies, such as the World Health Organization, the Malaria in Pregnancy Consortium, the Steve Biko Centre for Bioethics, and the London School of Hygiene and Tropical Medicine, in order to address the challenges just described, Pfizer Inc. and Medicines for Malaria Venture (the “Sponsoring Entities” for these studies) and investigators liaised with national- and district-level stakeholders such as health ministers and regional/local community health workers. Community engagement measures undertaken by investigators included local meetings with community leaders to explain the research aims and answer questions and concerns voiced by the community. The investigators also engaged with family members of prospective trial participants in order to be sensitive to local practices and beliefs. CONCLUSION: Engagement with key stakeholders at international and national levels enabled the Sponsoring Entities to address challenges by aligning the study design with the requirements of health and regulatory agencies and to understand and address healthcare infrastructure needs prior to trial initiation. Local stakeholder engagement, including community members, study participants, and family enabled the investigators to address challenges by ensuring that study design and conduct were adapted to local considerations and ensuring accurate information about the study aims was shared with the public. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT01103063. Registered on 7 April 2010. |
format | Online Article Text |
id | pubmed-5863846 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-58638462018-03-27 Multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settings Mtove, George Kimani, Joshua Kisinza, William Makenga, Geofrey Mangesho, Peter Duparc, Stephan Nakalembe, Miriam Phiri, Kamija S. Orrico, Russell Rojo, Ricardo Vandenbroucke, Pol Trials Commentary BACKGROUND: Multinational clinical trials are logistically complex and require close coordination between various stakeholders. They must comply with global clinical standards and are accountable to multiple regulatory and ethical bodies. In resource-limited settings, it is challenging to understand how to apply global clinical standards to international, national, and local factors in clinical trials, making multiple-level stakeholder engagement an important element in the successful conduct of these clinical trials. MAIN BODY: During the planning and implementation of a large multinational clinical trial for intermittent preventive treatment of malaria in pregnancy in resource-limited areas of sub-Saharan Africa, we encountered numerous challenges, which required implementation of a range of engagement measures to ensure compliance with global clinical and regulatory standards. These challenges included coordination with ongoing global malaria efforts, heterogeneity in national regulatory structures, sub-optimal healthcare infrastructure, local practices and beliefs, and perspectives that view healthcare providers with undue trust or suspicion. In addition to engagement with international bodies, such as the World Health Organization, the Malaria in Pregnancy Consortium, the Steve Biko Centre for Bioethics, and the London School of Hygiene and Tropical Medicine, in order to address the challenges just described, Pfizer Inc. and Medicines for Malaria Venture (the “Sponsoring Entities” for these studies) and investigators liaised with national- and district-level stakeholders such as health ministers and regional/local community health workers. Community engagement measures undertaken by investigators included local meetings with community leaders to explain the research aims and answer questions and concerns voiced by the community. The investigators also engaged with family members of prospective trial participants in order to be sensitive to local practices and beliefs. CONCLUSION: Engagement with key stakeholders at international and national levels enabled the Sponsoring Entities to address challenges by aligning the study design with the requirements of health and regulatory agencies and to understand and address healthcare infrastructure needs prior to trial initiation. Local stakeholder engagement, including community members, study participants, and family enabled the investigators to address challenges by ensuring that study design and conduct were adapted to local considerations and ensuring accurate information about the study aims was shared with the public. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT01103063. Registered on 7 April 2010. BioMed Central 2018-03-22 /pmc/articles/PMC5863846/ /pubmed/29566732 http://dx.doi.org/10.1186/s13063-018-2563-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Commentary Mtove, George Kimani, Joshua Kisinza, William Makenga, Geofrey Mangesho, Peter Duparc, Stephan Nakalembe, Miriam Phiri, Kamija S. Orrico, Russell Rojo, Ricardo Vandenbroucke, Pol Multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settings |
title | Multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settings |
title_full | Multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settings |
title_fullStr | Multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settings |
title_full_unstemmed | Multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settings |
title_short | Multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settings |
title_sort | multiple-level stakeholder engagement in malaria clinical trials: addressing the challenges of conducting clinical research in resource-limited settings |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5863846/ https://www.ncbi.nlm.nih.gov/pubmed/29566732 http://dx.doi.org/10.1186/s13063-018-2563-1 |
work_keys_str_mv | AT mtovegeorge multiplelevelstakeholderengagementinmalariaclinicaltrialsaddressingthechallengesofconductingclinicalresearchinresourcelimitedsettings AT kimanijoshua multiplelevelstakeholderengagementinmalariaclinicaltrialsaddressingthechallengesofconductingclinicalresearchinresourcelimitedsettings AT kisinzawilliam multiplelevelstakeholderengagementinmalariaclinicaltrialsaddressingthechallengesofconductingclinicalresearchinresourcelimitedsettings AT makengageofrey multiplelevelstakeholderengagementinmalariaclinicaltrialsaddressingthechallengesofconductingclinicalresearchinresourcelimitedsettings AT mangeshopeter multiplelevelstakeholderengagementinmalariaclinicaltrialsaddressingthechallengesofconductingclinicalresearchinresourcelimitedsettings AT duparcstephan multiplelevelstakeholderengagementinmalariaclinicaltrialsaddressingthechallengesofconductingclinicalresearchinresourcelimitedsettings AT nakalembemiriam multiplelevelstakeholderengagementinmalariaclinicaltrialsaddressingthechallengesofconductingclinicalresearchinresourcelimitedsettings AT phirikamijas multiplelevelstakeholderengagementinmalariaclinicaltrialsaddressingthechallengesofconductingclinicalresearchinresourcelimitedsettings AT orricorussell multiplelevelstakeholderengagementinmalariaclinicaltrialsaddressingthechallengesofconductingclinicalresearchinresourcelimitedsettings AT rojoricardo multiplelevelstakeholderengagementinmalariaclinicaltrialsaddressingthechallengesofconductingclinicalresearchinresourcelimitedsettings AT vandenbrouckepol multiplelevelstakeholderengagementinmalariaclinicaltrialsaddressingthechallengesofconductingclinicalresearchinresourcelimitedsettings |